The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Effect of selective LRRK2 kinase inhibition on nonhuman primate lung
Abstract
LRRK2 kinase inhibitors, under development for Parkinson’s disease, have an effect on type II pneumocytes in nonhuman primate lung, suggesting that pulmonary toxicity may be a critical safety liability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.005 · Cited by 3,005
Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease
Paisán-Ruı́z, C., Jain, S., Evans, E. W., Gilks, W. P., Simón, J., van der Brug, M., de Munain, A. L., Aparicio, S., Gil, A. M., Khan, N., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.10.023 · Cited by 2,405
Healy, D. G., Falchi, M., O'Sullivan, S. S., Bonifati, V., Durr, A., Bressman, S., Brice, A., Aasly, J., Zabetian, C. P., Goldwurm, S., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70117-0 · Cited by 1,425
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
West, A. B., Moore, D. J., Biskup, S., Bugayenko, A., Smith, W. W., Ross, C. A., Dawson, V. L., & Dawson, T. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507360102 · Cited by 1,228
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin
Greggio, E., Jain, S., Kingsbury, A., Bandopadhyay, R., Lewis, P., Kaganovich, A., van der Brug, M. P., Beilina, A., Blackinton, J., Thomas, K. J., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.001 · Cited by 671
Interplay of LRRK2 with chaperone-mediated autophagy
Orenstein, S. J., Kuo, S.-H., Tasset, I., Arias, E., Koga, H., Fernandez-Carasa, I., Cortes, E., Honig, L. S., Dauer, W., Consiglio, A., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3350 · Cited by 588
Kachergus, J., Mata, I. F., Hulihan, M., Taylor, J. P., Lincoln, S., Aasly, J., Gibson, J. M., Ross, O. A., Lynch, T., Wiley, J., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429256 · Cited by 541
The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
Cookson, M. R. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2935 · Cited by 539
Tong, Y., Yamaguchi, H., Giaime, E., Boyle, S., Kopan, R., Kelleher, R. J., & Shen, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004676107 · Cited by 501
The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity
Gloeckner, C. J., Kinkl, N., Schumacher, A., Braun, R. J., O'Neill, E., Meitinger, T., Kolch, W., Prokisch, H., & Ueffing, M. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi439 · Cited by 477
Recent Advances in the Genetics of Parkinson's Disease
Martin, I., Dawson, V. L., & Dawson, T. M. (2011) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082410-101440 · Cited by 437
Herzig, M. C., Kolly, C., Persohn, E., Theil, D., Schweizer, T., Hafner, T., Stemmelen, C., Troxler, T. J., Schmid, P., Danner, S., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr348 · Cited by 360
Sheng, Z., Zhang, S., Bustos, D., Kleinheinz, T., Le Pichon, C. E., Dominguez, S. L., Solanoy, H. O., Drummond, J., Zhang, X., Ding, X., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004485 · Cited by 353
Self-citationAmiodarone: Review of Pulmonary Effects and Toxicity
Papiris, S. A., Triantafillidou, C., Kolilekas, L., Markoulaki, D., & Manali, E. D. (2010) · Drug Safety · doi:10.2165/11532320-000000000-00000 · Cited by 241
Lysosomal Storage Disease: Revealing Lysosomal Function and Physiology
Parkinson-Lawrence, E. J., Shandala, T., Prodoehl, M., Plew, R., Borlace, G. N., & Brooks, D. A. (2010) · Physiology · doi:10.1152/physiol.00041.2009 · Cited by 220
Baptista, M. A. S., Dave, K. D., Frasier, M. A., Sherer, T. B., Greeley, M., Beck, M. J., Varsho, J. S., Parker, G. A., Moore, C., Churchill, M. J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080705 · Cited by 175
Self-citationLRRK2 expression linked to dopamine‐innervated areas
Galter, D., Westerlund, M., Carmine, A., Lindqvist, E., Sydow, O., & Olson, L. (2006) · Annals of Neurology · doi:10.1002/ana.20808 · Cited by 174
Dächsel, J. C., & Farrer, M. J. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.79 · Cited by 171
Estrada, A. A., Liu, X., Baker-Glenn, C., Beresford, A., Burdick, D. J., Chambers, M., Chan, B. K., Chen, H., Ding, X., DiPasquale, A. G., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301020q · Cited by 162
Self-citationDynamic and redundant regulation of LRRK2 and LRRK1 expression
Biskup, S., Moore, D. J., Rea, A., Lorenz-Deperieux, B., Coombes, C. E., Dawson, V. L., Dawson, T. M., & West, A. B. (2007) · BMC Neuroscience · doi:10.1186/1471-2202-8-102 · Cited by 158
Drug induced phospholipidosis: An acquired lysosomal storage disorder
Shayman, J. A., & Abe, A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.08.013 · Cited by 152
Law, B. M. H., Spain, V. A., Leinster, V. H. L., Chia, R., Beilina, A. G., Cho, H. J., Taymans, J., Urban, M. K., Sancho, R. M., Ramírez, M. B., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.507913 · Cited by 152
Estrada, A. A., Chan, B. K., Baker‐Glenn, C. A. G., Beresford, A. P., Burdick, D. J., Chambers, M. G., Chen, H., Domínguez, S. L., Dotson, J., Drummond, J., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401654j · Cited by 139
Self-citationGallala, H. D., & Sandhoff, K. (2011) · Neurochemical Research · doi:10.1007/s11064-010-0337-6 · Cited by 137
In situ validation of an intestinal stem cell signature in colorectal cancer
Ziskin, J. L., Dunlap, D. Y., Yaylaoglu, M., Fodor, I. K., Forrest, W. F., Patel, R., Ge, N., Hutchins, G. G. A., Pine, J. K., Quirke, P., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301195 · Cited by 119
Self-citationEffect of lysosomal storage on bis(monoacylglycero)phosphate
Meikle, P. J., Duplock, S. K., Blacklock, D., Whitfield, P. D., MacIntosh, G. L., Hopwood, J. J., & Fuller, M. (2008) · Biochemical Journal · doi:10.1042/bj20071043 · Cited by 97
NESS, D. K., Ren, Z., Gardai, S. J., Sharpnack, D. D., Johnson, V. J., Brennan, R., Brigham, E. F., & Olaharski, A. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066164 · Cited by 93
Bonifati, V. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9324-y · Cited by 82
Zfp423 Is Required for Normal Cerebellar Development
Warming, S., Rachel, R. A., Jenkins, N. A., & Copeland, N. G. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02255-05 · Cited by 80
Self-citationLiu, N., Tengstrand, E., Chourb, L. S., & Hsieh, F. Y. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.06.014 · Cited by 79
Tengstrand, E., Miwa, G. T., & Hsieh, F. Y. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425251003601961 · Cited by 60
Dzamko, N. L., Chua, G., Ranola, M., Rowe, D. B., & Halliday, G. M. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-130174 · Cited by 54
Mesens, N., Desmidt, M., Verheyen, G. R., Starckx, S., Damsch, S., Vries, R. D., Verhemeldonck, M., Gompel, J. V., Lampo, A., & Lammens, L. (2012) · Toxicologic Pathology · doi:10.1177/0192623311432290 · Cited by 51
Miklavc, P., Ehinger, K., Thompson, K. E., Hobi, N., Shimshek, D. R., & Frick, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084926 · Cited by 42
Update on the Functional Biology of Lrrk2
Melrose, H. L. (2008) · Future Neurology · doi:10.2217/14796708.3.6.669 · Cited by 41
Thompson, K. L., Zhang, J., Stewart, S. R., Rosenzweig, B. A., Shea, K. I., Mans, D. J., & Colatsky, T. J. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.07.013 · Cited by 16
Cited by
Defects in trafficking bridge Parkinson’s disease pathology and genetics
Abeliovich, A., & Gitler, A. D. (2016) · Nature · doi:10.1038/nature20414 · Cited by 462
Deyaert, E., Wauters, L., Guaitoli, G., Konijnenberg, A., Leemans, M., Terheyden, S., Petrovic, A., Gallardo, R., Nederveen-Schippers, L. M., Athanasopoulos, P. S., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01103-4 · Cited by 457
LRRK2 in Parkinson disease: challenges of clinical trials
Tolosa, E., Vila, M., Klein, C., & Rascol, O. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0301-2 · Cited by 438
LRRK2 kinase in Parkinson's disease
Alessi, D. R., & Sammler, E. (2018) · Science · doi:10.1126/science.aar5683 · Cited by 345
Machine translation of cortical activity to text with an encoder–decoder framework
Makin, J. G., Moses, D. A., & Chang, E. F. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0608-8 · Cited by 321
Metadata
- Authors
- Fuji, R. N., Flagella, M., Baca, M., S. Baptista, M. A., Brodbeck, J., Chan, B. K., Fiske, B. K., Honigberg, L., Jubb, A. M., Katavolos, P., Lee, D. W., Lewin-Koh, S.-C., Lin, T., Liu, X., Liu, S., Lyssikatos, J. P., O’Mahony, J., Reichelt, M., Roose-Girma, M., Sheng, Z., Sherer, T., Smith, A., Solon, M., Sweeney, Z. K., Tarrant, J., Urkowitz, A., Warming, S., Yaylaoglu, M., Zhang, S., Zhu, H., Estrada, A. A., & Watts, R. J.
- Venue
- Science Translational Medicine
- Published
- 2015-02-04
- Volume
- 7
- Issue
- 273
- Pages
- 273ra15-273ra15
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2040696002
- Cited by
- 352
- References
- 36
- FWCI
- 17.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.